Quantitative cancer risk analysis of BHA based on integration of pathological and biological/biochemical information.
Hayashi
Y
Y
Biological Safety Research Center, National Institute of Hygienic Sciences, Tokyo, Japan.
Morimoto
K
K
Miyata
N
N
Sato
H
H
D000818:Animals; D002083:Butylated Hydroxyanisole / Q000008:administration & dosage / Q000009:adverse effects* / Q000378:metabolism; D015197:Carcinogenicity Tests; D002277:Carcinoma / Q000139:chemically induced*; D002455:Cell Division; D006224:Cricetinae; D004249:DNA Damage; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D005527:Food, Fortified; D006801:Humans; D006965:Hyperplasia / Q000139:chemically induced; D008252:Macaca fascicularis; D008297:Male; D008647:Mesocricetus; D051379:Mice; D009152:Mutagenicity Tests; D010212:Papilloma / Q000139:chemically induced*; D051381:Rats; D011916:Rats, Inbred F344; D017208:Rats, Wistar; D013270:Stomach / Q000473:pathology*; D013274:Stomach Neoplasms / Q000139:chemically induced*
D002083:Butylated Hydroxyanisole